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In ras oncogene xpressing cells, bradykinin leads to intracellular alkalinization by activation of the Na’/H’ exchanger. This effect is paralleled 
by oscillatory increase of intracellular calcium activity and cell shrinkage. Staurosporine (1 PmoVl) is not sufficient o prevent bradykinin induced 
intracellular alkalinization, thus pointing to a protein kinase C independent pathway for the activation of Na’lH’ exchange. The present study 
has been performed to elucidate, whether the increase of intracellular calcium contributes to cell shrinkage and activation of the Na’lH‘ exchanger. 
To this end, the effects of the calcium ionophore ionomycin have been tested. Ionomycin leads to a dose dependent increase of intracellular calcium 
activity. At 100 nmol/l ionomycin intracellular calcium is increased from 114 + 17 nmol/l to 342 f 24 nmol/l (n = 9), a value within the range of 
intracellular calcium concentrations following application of bradykinin. The calcium increase is paralleled by a decrease of cell volume by 12 f 2% 
(n = 5) and an increase of intracellular pH from 6.78 2 0.02 to 6.90 * 0.03 (n = 1 1), values similar to those following application of bradykinin. 
The alkalinizing effect of ionomycin is completely abolished in the presence of the novel Na’/H’ exchange inhibitor HOE 694 (10 PmoYl), but is 
not inhibited by 1 PmoVl staurosporine. Inhibition of K’ and Cl- channels by barium (5 mmoV1) and ochratoxin-A (5 pmol/l) prevents both 
ionomycin induced cell shrinkage and protein kinase C independent intracellular alkalinization. It is concluded that bradykinin leads to intracellular 
alkalinization mainly by increasing intracellular calcium concentration. Calcium triggers calcium sensitive K’ channels, and presumably Cl- 
channels, the subsequent loss of cellular KCI leads to cell shrinkage which, in turn, activates Na’lH’ exchange. 
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1. INTRODUCTION 
In ras oncogene expressing NIH 3T3 fibroblasts 
bradykinin leads to sustained oscillations of intracellu- 
lar calcium activity [ 1,2], cell shrinkage and intracellular 
alkalinization [3]. If bradykinin induced cell shrinkage 
is prevented by a reduction of extracellular osmolarity, 
the alkalinizing effect of bradykinin is blunted [3]. Since 
the Na’/H’ exchanger has been found to serve cell vol- 
ume regulation in ras oncogene expressing NIH 3T3 
fibroblasts and to be activated by cell shrinkage [4], it 
was concluded that bradykinin mediated cell shrinkage 
participated in the activation of the Na’lH’ exchanger 
[3]. The mechanism underlying cell shrinkage remained, 
however, elusive. Circumstantial evidence pointed to 
the involvement of intracellular calcium: previous stud- 
ies have identified calcium sensitive K’ channels in these 
cells [l] and the bradykinin induced oscillations of intra- 
cellular calcium activity are paralleled by oscillations of 
cell membrane potential [2,5,6]. Activation of K’ chan- 
nels is an element of cell volume regulation and has been 
shown to shrink cells in a variety of tissues (for review 
see [7-91). Thus, it appeared conceivable that the 
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bradykinin induced increase of intracellular calcium 
participates in the stimulation of the Na’/H’ exchanger. 
The present study has been performed to test this hy- 
pothesis. To this end, the effects of the calcium iono- 
phore ionomycin on cell volume and intracellular pH 
have been investigated. As a result, ionomycin indeed 
shrinks the cells and leads to intracellular alkaliniza- 
tion. The alkalinization is abolished by HOE 694, a 
novel inhibitor of Na’/H’ exchange [lO,l 11. Both, iono- 
mycin induced cell shrinkage and protein kinase C inde- 
pendent intracellular alkalinization are abolished in the 
presence of K’ channel blocker barium and the putative 
Cl- channel blocker ochratoxin-A. 
Thus, the bradykinin induced rise in intracellular cal- 
cium serves to activate Na’/H’ exchange via activation 
of ion channels, loss of cellular KC1 and subsequent cell 
shrinkage. 
2. MATERIALS AND METHODS 
Experiments were performed on NIH 3T3 fibroblasts transfected 
with a transforming Ha-ras MMTV-LTR construct expressing the 
oncogene, which is pointmutated at position 12, upon a 24 h treatment 
with 1 pmol/l dexamethasone [12]. As controls served transfected cells 
not treated with dexamethasone. The increase of the expressed protein 
is routinely controlled by Western blot analysis [4]. 
The cells were grown on glass coverslips in Dulbecco’s modified 
Eagle’s medium (DMEM) at 37°C 5% COPS% air supplemented 
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with 100 g/l fetal calf serum (FCS) [12]. Prior to the experiments the 
cells were exposed to low serum medium (5 g/l FCS) for 24 h. 
BCECF fluorescence has been used for determination of intracellu- 
lar pH (pHi), fura- fluorescence for determination of intracellular 
calcium (Ca,). To this end, glass coverslips with incompletely confluent 
cell layers were incubated for 15 min with 3 pmol/l BCECF-acetox- 
ymethylester (Molecular Probes, Eugene, OR, USA) or 2.5 pmol/l 
fura- 2-AM (Molecular Probes, Junction City, OR, USA and Calbio- 
them, Geneva, Switzerland). Measurements were made under an in- 
verted phase-contrast microscope (IM-35; Zeiss, Oberkochen, Ger- 
many) equipped for epifluorescence and photometry (Hamamatsu, 
Herrsching, Germany) [13]. Light from a xenon arc lamp (XB075; 
Osram, Berlin, Germany) was directed through a grey-filter (nominal 
transmission 3.16%, Oriel, Darmstadt, Germany), and alternatingly 
through interference filters (halfwidth 10 nm, Oriel, Darmstadt, Ger- 
many) of 488 nm and 440 nm (for pH,) or 340 nm and 380 nm (for 
Ca), respectively, and a diaphragm and deflected by a dichroic mirror 
(FT510 (pH3 or FT420 (Ca), Zeiss, Oberkochen, Germany) into the 
objective (Plan-Neofluar 63 x oil immersion; Zeiss, Oberkochen, Ger- 
many). The emitted fluorescence was directed through a 530 nm (pH,) 
or 420 nm (Ca,) cutoff filter to a photomultiplier tube (R4829, Hama- 
matsu, Herrsching, Germany). To reduce the region from which fluo- 
rescence was collected a pinhole was placed in the image plane of the 
phototube (limitation to a circular area of 60 pm diameter). All fluo- 
rescence values were corrected for cellular autofluorescence. pH, was 
calibrated with the high potassium/nigericin technique [14]. Cai was 
calculated from the ratio (R) of the fluorescence intensities at the two 
different excitation wave lengths (340 nm/380 nm) [l,lS]: 
where R,,, and R,,, are the fluorescence ratios corrected for autofluo- 
rescence at experimental conditions, at minimum and maximum cal- 
cium binding; Kd is the dissociation constant for fura- (= 225); Sr and 
&,,are the proportionality coefficients for the fluorescence at 386 nm 
excitation of free and calcium bound dye, respectively. R,i, and S, 
were determined by exposure of the cells to 2 mmol/l Mn2+ + 20prnol/i 
A23187, R, and Sb2 after exposure of the cells to either 20 pmol/l 
digitonin (Sigma, Mumch, Germany) or 20 hmol/l A23187. 
Cell volume was measured by cell sizing using a Coulter counter 
(model ZM; Coulter Electronics, UK) adapted with a Coulter channe- 
lyzer (model Coulter S-plus). The cell volume was calculated from the 
medians of volume distribution curves [4]. During measurement cells 
were kept at 37°C. Absolute cell volumes were obtained using latex 
beads (13.7 ,um diameter; Coulter Electronics, UK) as standards. 
Shortly before the cell volume measurements he cells were dispersed 
by gentle treatment with calcium- and magnesium-free trypsin/EDTA 
containing balanced salt solution and resuspended in isotonic electro- 
lyte solution. The extracellular perfusate was composed of (all num- 
bers in mmol/l): NaCl 114, KC1 5.4, MgCl, 0.8, CaCl, 1.2, Na,HPO, 
0.8, NaH,PO, 0.2, NaHCO, 20 and glucose 5.5. The solution was 
equilibrated with 5% COr/95% air (pH 7.4). All chemicals were ob- 
tained from Sigma, Munich, Germany, unless specified otherwise. 
Applicable data are expressed as arithmetic means + standard error 
of the mean (S.E.M.). Statistical analysis was made by paired or 
unpaired r-test, where applicable. Statistically significant differences 
were assumed at P < 0.05. 
3. RESULTS 
As reported previously [3,4] expression of the Ha-ras 
oncogene leads to an increase in cell volume from 
2.0 + 0.05 pl (n = 10) to 2.6 + 0.04 pl (n = 17) and to an 
increase in intracellular pH (pH,) from 6.62 f 0.05 
(n = 16) to 6.81 + 0.02 (n = 51). Cells expressing the ras 
oncogene respond to bradykinin with a further increase 
in pHi by 0.16 f 0.05 pH units (n = 6) [3]. After one 
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Fig. 1. Effect of 100 nmol/l bradykinin on intracellular pH (pHi) of 
ras oncogene expressing NIH 3T3 fibroblasts. Closed symbols show 
the time course of alkalinization under control conditions. Open sym- 
bols show the time course after one hour of preincubation and in 
continuous presence of 1 pmol/l staurosporine. Arithmetic 
means f S.E.M., numbers in parenthesis indicate numbers of inde- 
pendent experiments. 
hour of preincubation and the continuous presence of 
staurosporine (1 pmol/l) which has been shown to in- 
hibit PKC activity in these cells [16] bradykinin still 
leads to intracellular alkalinization (by 0.15 f 0.03 pH 
units, n = 11; Fig. 1). Under control conditions the in- 
tracellular calcium concentration (Cai) in these cells is 
114 f 17 nmol/l (n = 9). As shown in Fig. 2, ionomycin 
(1, 10, 100 and 1,000 nmol/l) leads to a dose dependent 
increase in both, Cai (by 5 * 12, 87 f 28, 224 + 33 and 
936 + 164 nmol/l, resp., n = 8-9) and PHI (by 
0.03 * 0.02, 0.04 & 0.01, 0.11 + 0.02 and 0.20 f 0.02 
pH units, resp., n = 612). The ionomycin (100 nmol/l) 
induced increase in pHi is completely abolished in the 
presence of 10 pmol/l HOE 694 (dpHi = 0.01 + 0.01, 
n = 8; Fig. 3), a novel potent inhibitor of the Na’/I-I’ 
exchanger [IO], but is not significantly modified after 
one hour of preincubation and the continuous presence 
of 1 pmol/l staurosporine (dpHi = 0.11 * 0.03, n = 10; 
Fig. 5). Fig. 4 shows that the ionomycin induced in- 
crease in pHi is paralleled by a decrease in cell volume 
by 12 f 2% (n = 5). This decrease in cell volume @CV) 
is blunted in the presence of the K’ channel blocker 
barium (10 mmol/l; XV = 7 f 1 %, n = 6). In the pres- 
ence of both, barium (5 mmol/l) and the putative Cl- 
channel blocker ochratoxin-A (5 pmol/l) [17] the iono- 
mycin induced decrease in cell volume (dCV = 4 f l%, 
n = 6) is not significantly different from the volume of 
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Fig. 2. Dose-response relationship for ionomycin. (Left panel) Increase in intracellular calcium concentration (KaJ in NIH 3T3 fibroblasts 
expressing the ras oncogene by 1, 10, 100 and 1,000 nmoY1 ionomycin. (Right panel) Increase in intracellular pH (dpH,) in NIH 3T3 fibroblasts 
expressing the ras oncogene by 1, 10, 100 and 1,000 nmol/l ionomycin. Arithmetic means + S.E.M., numbers in parentheses indicate numbers of 
independent experiments. 
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Fig. 3. Effect of 100 nmol/l ionomycin on intracellular pH (pH,) in 
NIH 3T3 fibroblasts expressing the ras oncogene. Experiments were 
performed in both, the absence (closed symbols) and continuous pres- 
ence of Na+/H’ exchange inhibitor HOE 694 (10 pmol/l). Arithmetic 
means + S.E.M., numbers in parentheses indicate numbers of inde- 
pendent experiments. 
untreated cells (XV = 3 k l%, n = 5). Similarly the in- 
tracellular alkalinization observed in the presence of 
staurosporine is completely abolished by barium (5 
mmol/l) and ochratoxin-A (5 pmolll; dpHi = -0.01 
+ 0.02, n = 8; Fig. 5). 
4. DISCUSSION 
A variety of mitogenic signals has been shown to 
activate the Na’/H’ exchanger, leading - under appro- 
priate conditions - to intracellular alkalinization, one of 
the putative prerequisites for the initiation of cell prolif- 
eration (for review see [18-211). Similarly, the expres- 
sion of the Ha-ras oncogene leads to growth factor 
independent activation of the Na’/H’ exchanger fol- 
lowed by intracellular alkalinization [16,22-241. The ac- 
tivation of the Na’/H’ exchanger by mitogenic signals 
is thought to be secondary to protein phosphorylation 
by PKC [18,25]. However, in some reports the alkalini- 
zation induced by mitogenic signals [26-301, expression 
of Ha-ras oncogene [16] or cell shrinkage [31,32] has 
been shown to be independent of PKC activation. As 
shown in this study bradykinin induced alkalinization 
in Ha-ras oncogene expressing NIH 3T3 fibroblasts is 
similarly insensitive to treatment of the cells with stau- 
rosporine, pointing to an alternative, PKC independent 
pathway of Na’/H’ exchanger activation. As reported 
previously the alkalinization is paralleled by cell shrink- 
age [3] and oscillations of Cai [2]. The hormone induced 
cell shrinkage has been shown to participate in the acti- 
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vation of the Na’/H’ exchanger and may thus represent 
the alternative pathway. The pulsatile increase in Ca, 
leads to the activation of calcium sensitive K’ channels, 
oscillations of the cell membrane potential [1] and the 
subsequent loss of cellular ions and is expected to shrink 
the cells. As shown in this study an increase in Cai, 
induced by the calcium ionophore ionomycin, is indeed 
tightly coupled to an increase in pH, and to cell shrink- 
age. At a concentration of 100 nmol/l ionomycin in- 
creases Cai and pHi and decreases cell volume to values 
similar to those observed with bradykinin [2,3]. The 
ionomycin induced alkalinization is inhibited by the 
novel blocker of the Na’/H’ exchanger, HOE 694, but 
remains unaffected by treatment of the cells with stauro- 
sporine and is thus not due to a calcium mediated acti- 
vation of PKC [33]. Furthermore, ionomycin has been 
shown to lead to activation of Ca*’ dependent K’ chan- 
nels resulting in hyperpolarization or, under certain 
conditions, even oscillations of the cell membrane po- 
tential [5,11]. Accordingly, inhibition of K’ channels by 
barium blunts the ionomycin induced cell shrinkage. 
However, a complete inhibition of cell shrinkage re- 
quires the combined action of both, barium and ochra- 
toxin-A, which has recently been shown to be a very 
potent Cl- channel blocker [ 171. This manoeuvre is also 
sufficient to inhibit ionomycin induced intracellular al- 
kalinization in staurosporine treated cells. Thus both 
K+ and Cl- channels might be involved in calcium medi- 
ated cell shrinkage and activation of the Na’/H’ ex- 
changer. 
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Fig. 5. Increase in intracellular pH (dpH,) by 100 nmol/l ionomycin 
in NIH 3T3 fibroblasts expressing the ras oncogene. Closed circles 
show experiments after one hour preincubation and continuous pres- 
ence of 1 pmol/l staurosporine. Open circles show experiments after 
one hour of preincubation and continuous presence of 1 pmol/l stau- 
rosporine together with 5 mmoU1 barium and 5 pmol/l ochratoxin-A. 
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In conclusion, in Ha-ras oncogene expressing NIH 
3T3 fibroblasts bradykinin leads to intracellular alka- 
linization utilizing a PKC independent pathway by in- 
creasing intracellular calcium activity, activation of K’ 
and Cl- channels, cell shrinkage and subsequent volume 
regulatory activation of the Na’/H’ exchanger. The cal- 
cium mediated cell shrinkage - most likely by activation 
of ion channels - may, therefore, represent an important 
step in the action of mitogenic signals. 
80 - 
Acknowledgements: The authors gratefully acknowledge the valuable 
discussion with Prof. Dr. P. Deetjen. They are grateful to Prof. Dr. 
H. Grunicke and Doz. Dr. K. Maly for providing the Ha-ras oncogene 
transfected NIH 3T3 fibroblasts. The skilled technical assistance of G. 
Siber, S. David and G. Buemberger is acknowledged. HOE 694 was 
a kind gift from Drs. H.J. Lang and B. Schiilkens of Hoechst AG 
(Frankfurt, Germany). This study was supported by the Fonds zur 
Fiirderung der wissenschaftlichen Forschung, Grant P 8294 MED. 
I I I I I I 
0 100 200 300 400 500 
time [set] REFERENCES 
Fig. 4. Effect of 100 nmolll ionomycin on cell volume of NIH 3T3 
fibroblasts expressing the ras oncogene. Effect of ionomycin alone 
(closed circles), ionomycin in combination with 10 mmol/l barium 
(closed squares) and ionomycin together with 5 mmol/l barium plus 
5 PmoVl ochratoxin-A (closed triangles). Open circles refer to cells 
treated with the solvent only. Arithmetic means + S.E.M., numbers in 
[l] Lang, F., Friedrich, F., Kahn, E., Wall, E., Hammerer, M., 
Waldegger, S., Maly, K. and Grunicke, H. (1991) J. Biol. Chem. 
266, 49384942. 
parentheses indicate numbers of independent experiments. 
[2] W611, E., Waldegger, S., Lang, F., Maly, K. and Grunicke, H. 
(1992) PtIiigers Arch. 420, 208-212. 
[3] Ritter, M., Wiill, E., Haussinger, D. and Lang, F. (1992) FEBS 
Lett. 307, 3677370. 
264 
APHi 1 
May 1993 
’ (10) 
’ (8) 
I I I I I I 
0 120 240 360 480 600 
time [s] 
of independent experiments. 
Volume 322, number 3 FEBSLETTERS May 1993 
[4] Lang, F., Ritter, M., Well, E., Weiss, H., Haussinger, D., 
Hoflacher, J., Maly, K. and Grunicke, H. (1992) Pthigers Arch. 
420,424421. 
[S] Lang, F., Waldegger, S., W611, E., Ritter, M., Maly, K. and 
Grunicke, H. (1992) Pthigers Arch. 421, 416424. 
[6] W611, E., Weiss, H., Waldegger, S. and Lang, F. (1992) Eur. J. 
Pharmacol. 212, 105-107. 
[7j Grinstein, S. and Dixon, J. (1989) Physiol. Rev. 69, 417481. 
[8] Hoffmann, E.K. and Simonsen, L.O. (1989) Physiol. Rev. 69, 
315-382. 
[9] Lang, F., Viilkl, H. and Hiussinger, D. (1990) Comp. Physiol. 4, 
l-25. 
[lo] Schmid, A., Scholz, W., Lang, H.J. and Popp, R. (1992) Biochem. 
Biophys. Res. Commun. 184, 112-l 17. 
[ll] Ritter, M., Wall, E., Waldegger, S., Haussinger, D., Lang, H.J., 
Scholz, W., Schiilkens, B. and Lang, F. (1993) Pfltigers Arch. (in 
press). 
[12] Jaggi, R., Salmons, B., Muellener, D. and Groner, B. (1986) 
EMBO J. 5, 2609-2612. 
[13] Almers, W. and Neher, E. (1985) FEBS Lett. 192, 13-17. 
[14] Ganz, M.B., Boyarsky, G., Sterzel, R.B. and Boron, W.F. (1989) 
Nature 337, 6488651. 
[15] Grynkiewicz, G., Poenie, M. and Tsien, R.Y. (1985) J. Biol. 
Chem. 2601. 344&3450. 
[16] Maly, K., Uberall, F., Loferer, H., Doppler, W., Oberhuber, H., 
Groner, B. and Grunicke, H. (1989) J. Biol. Chem. 264, 11839- 
11842. 
[17] Gekle, M., Oberleithner, H. and Silbernagl, S. (1992) JASN 3, 
124. 
[18] Counillon, L. and Pouyssegur, J. (1992) Cell. Physiol. Biochem. 
2, 138-149. 
[19] Gillies, B., Martinez-Zaguilan, R., Peterson, E.P. and Perona, R. 
(1992) Cell. Physiol. Biochem. 2, 159-179. 
[20] Nelson, N., Beltran, C., Supek, F. and Nelson, H. (1992) Cell. 
Physiol. Biochem. 2, 150-158. 
[21] Oberleithner, H. (1992) Cell. Physiol. Biochem. 2, 180-188. 
[22] Doppler, W., Jaggi, R. and Groner, B. (1987) Gene 54, 147-153. 
(231 Hagag, N., Lacal, J.C., Graber, M., Aaronson, S. and Viola, 
M.V. (1987) Mol. Cell. Biol. 7, 1984-1988. 
[24] Maly, K., Oberhuber, H., Doppler, W., Hoflacher, R., Jaggi, R., 
Groner, B. and Grunicke, H.H. (1989) Adv. Enzyme Regul. 27, 
121-131. 
[25] Moolenaar, W.H. (1986) Annu. Rev. Physiol. 48, 363-376. 
[26] Daniel, T.O. and Ives, H.E. (1987) Biochem. Biophys. Res. Com- 
mun. 145,111-117. 
[27] Ostrowski, J., Meier, K.E., Stanton, T.H., Smith, L.L. and 
Bobsztyk, K. (1988) J. Biol. Chem. 263, 1378613790. 
[28] Redondo, J.M., Lopez-Rivas, A., Vila, V., Cragoe Jr., E.J. and 
Fresno, M. (1988) J. Biol. Chem. 263, 17467-17470. 
[29] Smith, L.L., Stanton, T.H., Calalb, M.B. and Bombsztyk, K. 
(1988) J. Biol. Chem. 263, 7359-7363. 
[30] Vara, F. and Rozengurt, E. (1985) Biochem. Biophys. Res. Com- 
mun. 130, 646653. 
[31] Davis, B.A., Hogan, E.M. and Boron, W.F. (1992) Am. J. Phys- 
iol. 262, C533-CS36. 
[32] Grinstein, S., Mack, E. and Mills, G.B. (1986) Biochem. Biophys. 
Res. Commun. 134, 8-13. 
[33] Nishizuka, Y. (1984) Nature 308, 693-697. 
265 
